Oxford Nanopore Technologies plc (LON:ONT)
112.10
-0.20 (-0.18%)
Jul 20, 2026, 2:00 PM GMT
Oxford Nanopore Technologies Employees
Oxford Nanopore Technologies had 1,316 employees as of December 31, 2025. The number of employees decreased by 66 or -4.78% compared to the previous year.
Employees
1,316
Change
-66
Growth
-4.78%
Revenue / Employee
170.14K GBP
Profits / Employee
-110.33K GBP
Market Cap
1.10B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 1,316 | -66 | -4.78% |
| Dec 31, 2024 | 1,382 | 144 | 11.63% |
| Dec 31, 2023 | 1,238 | 229 | 22.70% |
| Dec 31, 2022 | 1,009 | 206 | 25.65% |
| Dec 31, 2021 | 803 | 276 | 52.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Genus | 3,190 |
| Oxford Biomedica | 977 |
| hVIVO | 376 |
| 4basebio | 140 |
| PureTech Health | 90 |
| Avacta Group | 81 |
| Scancell Holdings | 60 |
| Faron Pharmaceuticals Oy | 33 |
Oxford Nanopore Technologies News
- 7 days ago - UK Stock Market News: PageGroup, ME Group, Oxford Nanopore - The Armchair Trader
- 7 days ago - Oxford Nanopore Technologies Earnings release: H1 2026 - Filings
- 9 days ago - Oxford Nanopore price target lowered to 220 GBp from 240 GBp at Citi - TheFly
- 4 months ago - Oxford Nanopore price target raised to 172 GBp from 170 GBp at Barclays - TheFly
- 4 months ago - Oxford Nanopore price target lowered to 225 GBp from 300 GBp at RBC Capital - TheFly
- 4 months ago - Oxford Nanopore and A.D.A.M. Innovations Announce International Collaboration to Accelerate Advanced Genomic Medicine in Japan - Business Wire
- 4 months ago - Oxford Nanopore Technologies Transcript: Barclays 28th Annual Global Healthcare Conference - Transcripts
- 4 months ago - ViruSure Launches First GMP-Validated Viral Safety Test Based on Oxford Nanopore Sequencing - Business Wire